{"id":"W2922958791","doi":"10.1016/j.berh.2018.12.002","title":"An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis","year":2018,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Certolizumab pegol; Golimumab; Psoriatic arthritis; Secukinumab; Ustekinumab; Adalimumab; Infliximab; Etanercept; Abatacept; Dermatology; Psoriasis; Ixekizumab; Tofacitinib; Ankylosing spondylitis; Anakinra; Rheumatoid arthritis; Immunology; Internal medicine; Disease; Tumor necrosis factor alpha; Rituximab; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008758532,0.0007666539,0.006418933,0.0009370401,0.0003215303,0.00009497894,0.0005332665,0.001064849,0.0002467636],"category_scores_gemma":[0.0353724,0.0006345068,0.0007364809,0.001236779,0.002591361,0.0004620241,0.0006797435,0.00243889,0.0004188784],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001820084,"about_ca_system_score_gemma":0.001722168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001168702,"about_ca_topic_score_gemma":0.0004874831,"domain_scores_codex":[0.9849485,0.006961133,0.003869171,0.001760415,0.001079448,0.001381381],"domain_scores_gemma":[0.9805729,0.01481914,0.001346503,0.001519008,0.0007977951,0.0009446787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009360398,0.004008899,0.007671966,0.01725857,0.0006346118,0.001460651,0.0001542078,1.467996e-8,7.460552e-8,0.001439143,0.0002133861,0.9662224],"study_design_scores_gemma":[0.01116621,0.01176253,0.001857432,0.1481736,0.001609572,0.00365817,0.0008740015,0.00003021664,1.755042e-7,0.0009707818,0.8190395,0.0008578515],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03573144,0.9600138,0.000001832582,0.0003495049,0.0006220643,0.002801362,0.0001615677,0.00004884954,0.0002695919],"genre_scores_gemma":[0.009290476,0.988658,0.0009479281,0.00005367888,0.0001610328,0.0004873872,0.0002531391,0.0001142797,0.00003413351],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9653646,"threshold_uncertainty_score":0.9998626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3262066840566122,"score_gpt":0.5660123326610049,"score_spread":0.2398056486043927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}